Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37306936)
Watch
English
Unwelcome complement
scientific article published on 04 August 2009
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
2727567
retrieved
19 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
Unwelcome complement
(English)
1 reference
stated in
Europe PubMed Central
PMCID
2727567
retrieved
19 August 2017
author
John D. Lambris
object named as
John D Lambris
series ordinal
2
0 references
Maciej M Markiewski
series ordinal
1
object named as
Maciej M Markiewski
1 reference
stated in
Europe PubMed Central
PMCID
2727567
retrieved
19 August 2017
language of work or name
English
0 references
publication date
4 August 2009
1 reference
stated in
Europe PubMed Central
PMCID
2727567
retrieved
19 August 2017
published in
Cancer Research
1 reference
stated in
Europe PubMed Central
PMCID
2727567
retrieved
19 August 2017
volume
69
1 reference
stated in
Europe PubMed Central
PMCID
2727567
retrieved
19 August 2017
issue
16
1 reference
stated in
Europe PubMed Central
PMCID
2727567
retrieved
19 August 2017
page(s)
6367-6370
1 reference
stated in
Europe PubMed Central
PMCID
2727567
retrieved
19 August 2017
cites work
Myeloid-derived suppressor cells: linking inflammation and cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
6 September 2017
Myeloid-derived suppressor cells as regulators of the immune system
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
6 September 2017
Cancer and complement
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
6 September 2017
The role of membrane complement regulatory proteins in cancer immunotherapy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
6 September 2017
Modulation of the antitumor immune response by complement
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
6 September 2017
Complexity of complement activation in sepsis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
6 September 2017
Cancer-related inflammation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
6 September 2017
The role of complement in inflammatory diseases from behind the scenes into the spotlight
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
6 September 2017
Complement as effector system in cancer immunotherapy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
6 September 2017
Drug evaluation: the C5a receptor antagonist PMX-53.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
6 September 2017
Ascitic complement system in ovarian cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
6 September 2017
Inflammation and cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
6 September 2017
Points of control in inflammation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
6 September 2017
Inflammation and cancer: back to Virchow?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
6 September 2017
Persistent complement activation on tumor cells in breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
6 September 2017
Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
14 September 2017
Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
2 September 2018
Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
2 September 2018
Activity and activation of the complement system in patients being operated on for cancer of the colon.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727567
retrieved
2 September 2018
Cancer exploiting complement: a clue or an exception?
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/19654288
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1158/0008-5472.CAN-09-1918
1 reference
stated in
Europe PubMed Central
PMCID
2727567
retrieved
19 August 2017
PMCID
2727567
1 reference
stated in
Europe PubMed Central
PMCID
2727567
retrieved
19 August 2017
PubMed ID
19654288
1 reference
stated in
Europe PubMed Central
PMCID
2727567
retrieved
19 August 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit